Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-02-15

Clinical Trial Update: D-dimer Assay for the Exclusion of Intra-atrial Thrombus Risk Before Ablation of Atrial Fibrillation [NA]

View source ↗

Summary

A completed clinical trial evaluating a D-dimer assay to exclude intra-atrial thrombus risk prior to ablation in atrial fibrillation patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Groupe Hospitalier de la Rochelle Ré Aunis | Conditions: Atrial Fibrillation | NA | Status: COMPLETED | Results posted: 2019-02-15